Literature DB >> 17505781

Hemodynamic response to intravitreal triamcinolone in eyes with macular edema: intravitreal triamcinolone and ocular blood flow.

Osman Cekiç1, Yavuz Bardak, Sahin U Tiğ, Aykut Demirkol, Mustafa M Ekim, Onem Altintaş, Ahmet Yeşildağ, Orhan Oyar.   

Abstract

PURPOSE: To assess ocular hemodynamic response to intravitreal triamcinolone in patients with macular edema due to diabetes or retinal vein occlusion.
METHODS: Forty-three patients that were injected by intravitreal triamcinolone acetonide (0.1 cc 4 mg) for unilateral macular edema due to diabetes mellitus (n = 17) and occlusion of retinal vein (n = 26) underwent ocular hemodynamic evaluation by color Doppler imaging (CDI) before and one, two and three months after injection. Non-injected fellow eyes as well as 16 healthy volunteers were also evaluated.
RESULTS: In patients with diabetic macular edema, there was no hemodynamic difference between eyes to be injected and non-injected at baseline (P > 0.23). Compared to controls, a significant difference existed in the ophthalmic artery resistant index (P = 0.001) and end-diastolic velocity (P < 0.001) in diabetics. At one month, compared to fellow eyes, change in end diastolic velocity from baseline in treated eyes was significantly decreased in posterior ciliary arteries (0.68 +/- 0.34 cm/s [mean +/- SEM] vs. -1.04 +/- 0.81 cm/s, P = 0.012). Throughout the study period, no significant alteration from baseline in the resistant index of any artery was noted in treated diabetic eyes (P > 0.05). In eyes with retinal vein occlusion, baseline CDI evaluation demonstrated reduced posterior ciliary arteries systolic flow velocity compared to fellow and control eyes (13.24 +/- 1.04 cm/s, 16.37 +/- 0.76 cm/s and 14.33 +/- 1.41 cm/s, respectively, P = 0.007). Increased peak systolic velocity in the posterior ciliary arteries at one week (P = 0.02), one month (P = 0.005) and two months (P = 0.04), and increase in central retinal artery resistant index at one month was noted (P = 0.05).
CONCLUSION: Intravitreal triamcinolone temporarily changed central retinal artery blood flow and posterior ciliary arteries' peak systolic blood velocity in eyes with retinal vein occlusion whilst no response of blood flow to triamcinolone injection but only transiently altered end diastolic blood velocity in posterior ciliary arteries was observed in diabetic eyes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17505781     DOI: 10.1007/s10792-007-9080-7

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  17 in total

1.  Potentiation of the vasoconstrictor action of topical norepinephrine on the human bulbar conjuctival vessels after topical application of certain adrenocortical hormones.

Authors:  D J REIS
Journal:  J Clin Endocrinol Metab       Date:  1960-03       Impact factor: 5.958

2.  Intravitreal triamcinolone injection for treatment of macular edema secondary to branch retinal vein occlusion.

Authors:  Osman Cekiç; Stanley Chang; Joseph J Tseng; Gaetano R Barile; Lucian V Del Priore; Harold Weissman; William M Schiff; Michael D Ober
Journal:  Retina       Date:  2005 Oct-Nov       Impact factor: 4.256

3.  Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.

Authors:  Osman Cekiç; Stanley Chang; Joseph J Tseng; Gaetano R Barile; Harold Weissman; Lucian V Del Priore; William M Schiff; Michael Weiss; James M Klancnik
Journal:  Retina       Date:  2005 Oct-Nov       Impact factor: 4.256

4.  Colour Doppler imaging of the ocular circulation in diabetic retinopathy.

Authors:  J R MacKinnon; G McKillop; C O'Brien; K Swa; Z Butt; P Nelson
Journal:  Acta Ophthalmol Scand       Date:  2000-08

5.  Impaired retinal autoregulation in small retinal arterioles before and after focal laser treatment for diabetic maculopathy.

Authors:  P Jeppesen; T Bek
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

6.  Pulsatile ocular blood flow change after treatment with systemic steroid in patients with Graves' ophthalmopathy.

Authors:  C-C Tsai; H-C Kau; H-H Tsai; S-C Kao; W-M Hsu
Journal:  Eye (Lond)       Date:  2005-08-26       Impact factor: 3.775

7.  Color Doppler imaging: a new technique to assess orbital blood flow in patients with diabetic retinopathy.

Authors:  W Goebel; W E Lieb; A Ho; R C Sergott; R Farhoumand; F Grehn
Journal:  Invest Ophthalmol Vis Sci       Date:  1995-04       Impact factor: 4.799

8.  The blood pressure-induced diameter response of retinal arterioles decreases with increasing diabetic maculopathy.

Authors:  Christian Alcaraz Frederiksen; Peter Jeppesen; Søren Tang Knudsen; Per Løgstrup Poulsen; Carl Erik Mogensen; Toke Bek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-03-15       Impact factor: 3.117

9.  Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells.

Authors:  M Sakaue; B B Hoffman
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

10.  Aldosterone and dexamethasone binding in human arterial smooth muscle cells.

Authors:  B A Scott; B Lawrence; H H Nguyen; W J Meyer
Journal:  J Hypertens       Date:  1987-12       Impact factor: 4.844

View more
  3 in total

1.  Vessel diameter study: intravitreal vs posterior subtenon triamcinolone acetonide injection for diabetic macular edema.

Authors:  M M Kurt; O Çekiç; Ç Akpolat; M Aslankurt; M Elçioğlu
Journal:  Eye (Lond)       Date:  2017-03-24       Impact factor: 3.775

2.  Short-term effects of intravitreal triamcinolone acetonide injection on ocular blood flow evaluated with color Doppler ultrasonography.

Authors:  Mustafa Alpaslan Anayol; Yasin Toklu; Elif Asik Kamberoglu; Sabri Raza; Hasan Basri Arifoglu; Huseyin Simavli; Ayse Gul Kocak Altintas; Saban Simsek
Journal:  Int J Ophthalmol       Date:  2014-10-18       Impact factor: 1.779

3.  The short-term effects of intravitreal aflibercept injections and dexamethasone implant on ocular hemodynamics in retinal vein occlusions.

Authors:  Emine Ciloglu; Ayse Yıldırım Celikdemir
Journal:  Ther Clin Risk Manag       Date:  2019-07-04       Impact factor: 2.423

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.